is semaglutide still in short supply US judge upholds FDA's removal of Ozempic, Wegovy from drug shortage list Type 2 diabetes: New Ozempic

While most major insurers and Medicare plans cover GLP-1s for T2D, coverage for GLP-1s for obesity and weight management is much more limited and often excluded from standard plans

Sounds great, right

While 80% of the market currently uses subcutaneous injection, the oral segment is projected to grow at the fastest rate through 2030

Researchers who establish communication with their vendor early in the relationship often have smoother experiences when issues inevitably arise, whether that involves a shipping question, a COA clarification, or a product concern

Glucagon-Like Peptide 1 Undergoes Differential Tissue-Specific Metabolism in the Anesthetized Pig

My results are better than expected